Upgrade to SI Premium - Free Trial

Albemarle (ALB) PT Lowered to $150 at UBS

October 5, 2026 9:04 AM
UBS analyst Joshua Spector lowered the price target on Albemarle (NYSE: ALB) to $150.00 (from $175.00) while maintaining a Buy rating.

Categories

Analyst PT Change